Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'pi3 kinase p110'

Search results for: 'pi3 kinase p110'

Items 121-130 of 203

Page
per page
  1. LY2606368
    B1088 LY2606368
    Target: Chk
    Summary: CHK1 inhibitor
      insoluble in DMSO
  2. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  3. LGX818
    B1174 LGX818
    Target: Raf
    Summary: RAF inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥13.38 mg/mL
  4. GW441756
    B2297 GW441756
     1 Citation
    Target: Trk Receptors
    Summary: TrkA inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥13.75 mg/mL
  5. ZIP (SCRAMBLED)
    A8830 ZIP (SCRAMBLED)
    Summary: PKMζ inhibitor
      ≥192.8 mg/mL
  6. Trametinib (GSK1120212)
    A3018 Trametinib (GSK1120212)
     7 Citation
    Target: MEK
    Summary: MEK1 and MEK2 inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
  7. AZD5363
    A1387 AZD5363
     3 Citation
    Target: Akt
    Summary: AKT inhibitor,pyrrolopyrimidine derived
      ≥21.45 mg/mL
  8. A-674563
    A8616 A-674563
    Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK
    Summary: Akt1/PKA/CDK2 inhibitor,potent and selective
      insoluble in EtOH; ≥23.8 mg/mL
  9. K145
    B1298 K145
    Target: Sphingosine kinases (SphKs)
    Summary: SphK2 inhibitor
      Soluble in DMSO
  10. SMI-4a
    A4193 SMI-4a
    Target: Pim
    Summary: Potent Pim inhibitor
      insoluble in H2O; ≥13.65 mg/mL

Items 121-130 of 203

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 200item
  2. Natural Products 1 item
  3. Lab Reagents 1 item
Specificity
  1. Selective 128item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 10item
  2. Irreversible 5item
Target
  1. Cyclin-Dependent Kinases 17item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 3item
  4. PI3K 9item
  5. Raf 8item
  6. Aurora Kinases 16item
  7. CSF-1R 4item
  8. mTOR 6item
  9. FLT3 11item
  10. GSK-3 5item
  11. PLK 5item
  12. Chk 3item
  13. Eph Receptors 2item
  14. VEGFR 22item
  15. PDGFR 16item
  16. c-Kit 9item
  17. RET 2item
  18. IRAK 1 item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. p38 4item
  21. PKB 1 item
  22. Bcr-Abl 8item
  23. MEK 2item
  24. FGFR 8item
  25. Pim 3item
  26. Voltage-gated Sodium (NaV) Channels 1 item
  27. MET 3item
  28. Src 13item
  29. Trk Receptors 1 item
  30. STAT 2item
  31. EGFR 14item
  32. ROCK 3item
  33. FAK 2item
  34. JAK 12item
  35. Syk 3item
  36. DNA-PK 3item
  37. AMPK 1 item
  38. Cytochrome P450 (CYP450) 1 item
  39. ErbB 3item
  40. ERK 3item
  41. c-MET 4item
  42. PKC 9item
  43. Ca2 /calmodulin-dependent protein kinases (CaMKs) 3item
  44. Lyn 1 item
  45. Pyk2 2item
  46. LRRK2 5item
  47. Insulin and Insulin-like Receptors 3item
  48. ALK 4item
  49. Sphingosine kinases (SphKs) 2item
  50. PKG 1 item
  51. PKA 3item
  52. Myosin light chain kinases (MLCKs) 1 item
  53. MK2 1 item
  54. Angiotensin-Converting Enzymes (ACEs) 1 item
  55. Tie-2 1 item
  56. RSK 2item
  57. phosphatases 1 item
  58. ATM/ATR 3item
  59. Farnesyl Diphosphate Synthases 1 item
  60. CK2 3item
  61. HIPK2 1 item
  62. HIPK3 1 item
  63. P2X Receptors 1 item
  64. P110 1 item
  65. Hck 2item
  66. MNK 1 item
  67. 5-Lipoxygenases 1 item
  68. Insulin Receptors 1 item
  69. IRG-1R 1 item
  70. Cdc2-like kinase (Clk) 1 item
  71. eEF-2 1 item
  72. Cdc7 1 item
  73. ZAP-70 1 item
  74. c-RET 3item
  75. p70 rsk 2item
  76. VEGFR3/FLT4 1 item
  77. NTRK1/TRKA 1 item
  78. CSF-1R/c-Fms 1 item
  79. TAM kinase 1 item
  80. KDR 1 item
  81. Fyn kinase 1 item
  82. Abl kinases 1 item
  83. AXL 1 item
  84. c-Fms tyrosine kinase 1 item
  85. insulin 1 item
  86. STK 1 item
  87. MSK 1 item
  88. Lyn kinase 1 item
  89. Mer tyrosine kinase 1 item
  90. ErbB-2 1 item
  91. PDK-1 1 item
  92. Histone Acetyltransferases (HATs) 1 item
  93. Prk 1 item
  94. ITK 1 item
  95. NUAK 1 item
  96. DCLK2 1 item
  97. PTK 1 item
  98. phosphatidylinositol kinase 1 item
  99. Lck 1 item
  100. Flk1 2item
  101. glutamate release 1 item
  102. FGR 1 item
  103. YES 2item
  104. Fyn 2item
  105. ARG 1 item
  106. PKD 1 item
  107. Pyruvate kinases 1 item
  108. enoyl-acyl-carrier protein reductase 1 item
  109. Rho-kinase 1 item
  110. tropomyosin receptor kinase 1 item
  111. SK 1 item
  112. PPK 1 item
  113. c-Syk 1 item
  114. CDK1/CyclinB 1 item
  115. PIM1 kinase 1 item
  116. phospholipase A2 1 item
  117. PIKfyve 1 item
  118. Insulin Receptor 1 item
Related Disease
  1. Acute Myeloid Leukemia 10item
  2. Adrenocortical Carcinoma 2item
  3. Bladder Cancer 2item
  4. Bladder Carcinoma 1 item
  5. B-lymphoid Malignancies 1 item
  6. Breast Cancer 21item
  7. Cancer 120item
  8. Cervical Cancer 3item
  9. Cholangiocarcinoma 1 item
  10. Chronic Lymphocytic Leukemia 1 item
  11. Clear Cell Renal Cell Carcinoma 1 item
  12. Colon Cancer 9item
  13. Colon Carcinoma 1 item
  14. Colorectal Cancer 13item
  15. Glioblastoma 9item
  16. Glioma 4item
  17. Hepatocellular Carcinoma 3item
  18. HIV Infections 1 item
  19. Leukemia 6item
  20. Liver Cancer 2item
  21. Lung Cancer 5item
  22. Lung Carcinoma 1 item
  23. Lymphoma 7item
  24. Mantle Cell Lymphoma 1 item
  25. Melanoma 7item
  26. Multiple Myeloma 3item
  27. Myelofibrosis 1 item
  28. Non-small Cell Lung Cancer 4item
  29. Ovarian Cancer 9item
  30. Pancreatic Cancer 13item
  31. Prostate Cancer 7item
  32. Psoriasis 1 item
  33. Renal Cancer 2item
  34. Renal Cell Carcinoma 2item
  35. Rheumatoid Arthritis 4item
  36. Thyroid Cancer 3item
  37. Type 2 Diabetes 1 item